|
HSP90AA1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.269600E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.289500E-02 |
| Normal-vs-Stage2 |
1.363980E-01 |
| Normal-vs-Stage3 |
5.540200E-02 |
| Normal-vs-Stage4 |
4.422500E-02 |
| Stage1-vs-Stage2 |
9.190400E-01 |
| Stage1-vs-Stage3 |
3.682800E-01 |
| Stage1-vs-Stage4 |
2.394600E-01 |
| Stage2-vs-Stage3 |
7.535400E-01 |
| Stage2-vs-Stage4 |
6.456600E-01 |
| Stage3-vs-Stage4 |
7.981400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.196400E-02 |
| Normal-vs-AfricanAmerican |
1.193400E-01 |
| Normal-vs-Asian |
3.359400E-01 |
| Caucasian-vs-AfricanAmerican |
9.436200E-01 |
| Caucasian-vs-Asian |
2.961400E-01 |
| AfricanAmerican-vs-Asian |
4.462400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.923500E-02 |
| Normal-vs-Female |
1.032430E-01 |
| Male-vs-Female |
4.685800E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.399010E-01 |
| Normal-vs-Age(41-60Yrs) |
8.549900E-02 |
| Normal-vs-Age(61-80Yrs) |
2.272000E-02 |
| Normal-vs-Age(81-100Yrs) |
2.224000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.239400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.396270E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.664400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.586200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.634020E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.318600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.249910E-02 |
| Classical-VS-Follicular |
4.90560000399043E-08 |
| Classical-VS-Other |
2.201800E-01 |
| Classical-VS-Normal |
2.103000E-01 |
| Tall-VS-Follicular |
4.436400E-02 |
| Tall-VS-Other |
8.229600E-01 |
| Tall-VS-Normal |
3.632000E-02 |
| Follicular-VS-Other |
5.982000E-01 |
| Follicular-VS-Normal |
3.340400E-03 |
| Other-VS-Normal |
3.284800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.835800E-02 |
| Normal-vs-N1 |
1.875500E-02 |
| N0-vs-N1 |
2.538800E-01 |
|
|
